1333472-81-3

Basic information

• Product Name: 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-methoxyacetic acid
• Synonyms: 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-methoxyacetic acid
• CAS NO: 1333472-81-3
• Molecular Weight: 233.227
• Mol File: 1333472-81-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-methoxyacetic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-methoxyacetic acid(1333472-81-3)
• EPA Substance Registry System: 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-2-methoxyacetic acid(1333472-81-3)

Safety Data

• Hazardous Substances Data: 1333472-81-3(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 75-25-2 Bromoform 
• 179056-04-3 4-(2H-1,2,3-triazol-2-yl)benzaldehyde 

Downstream Products

• 1333472-82-4 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-N,2-dimethoxy-N-methylacetamide 
• 1333471-64-9 2-(4-(2H-1,2,3-triazol-2-yl)phenyl)-1-(5-(4-bromo-3,5-dimethoxyphenyl)furan-2-yl)-2-methoxyethanone 

Relevant articles and documents

PDE10 INHIBITORS AND RELATED COMPOSITIONS AND METHODS

Compounds that inhibit PDE10 are disclosed that have utility in the treatment of a variety of conditions, including (but not limited to) psychotic, anxiety, movement disorders and/or neurological disorders such as Parkinson's disease, Huntington's disease, Alzheimer's disease, encephalitis, phobias, epilepsy, aphasia, Bell's palsy, cerebral palsy, sleep disorders, pain, Tourette's syndrome, schizophrenia, delusional disorders, drug-induced psychosis and panic and obsessive-compulsive disorders. Pharmaceutically acceptable salts, stereoisomers, solvates and prodrugs of the compounds are also provided. Also disclosed are compositions containing a compound in combination with a pharmaceutically acceptable carrier, as well as methods relating to the use thereof for inhibiting PDE10 in a warm-blooded animal in need of the same.